Workflow
CITIC Securities Co., Ltd.(CIIHY)
icon
Search documents
康希诺跌3.73% 2020年上市募52亿元中信证券保荐
Zhong Guo Jing Ji Wang· 2026-01-27 08:30
中信证券投资有限公司(参与跟投的保荐机构相关公司)获配股票数量为49.60万股,占本次发行总股 数的2.00%,跟投金额为1.04亿元。 (责任编辑:马欣) 康希诺首次公开发行股票募集资金总额为52.01亿元,扣除发行费用后,募集资金净额为49.79亿元。康 希诺最终募集资金净额较原计划多39.79亿元。康希诺于2020年8月6日发布的招股说明书显示,该公司 计划募集资金10亿元,分别用于"生产基地二期建设""在研疫苗开发""疫苗追溯、冷链物流体系及信息 系统建设""补充流动资金"。 康希诺首次公开发行股票的发行费用为2.21亿元,其中保荐及承销费用2.05亿元。 中国经济网北京1月27日讯 康希诺(688185.SH)今日股价下跌,截至收盘,该股报74.33元,跌幅3.73%。 该股目前处于破发状态。 康希诺于2020年8月13日在上交所科创板上市,发行数量为2480万股,发行价格209.71元/股,保荐机构 (主承销商)为中信证券,保荐代表人为焦延延、马可;联席主承销商为中金公司,副主承销商为渤海 证券。 ...
华依科技连亏3年 2021上市两募资共8亿中信证券保荐
Zhong Guo Jing Ji Wang· 2026-01-27 07:44
Group 1 - The company, Huayi Technology (688071.SH), has disclosed its performance forecast for 2025, expecting a net profit attributable to shareholders of the parent company to be between -53.5 million and -64 million yuan [1] - The projected net profit, excluding non-recurring gains and losses, is estimated to be between -56.31 million and -66.81 million yuan for 2025 [1] - The net profits for the years 2023, 2024, and the first half of 2025 are reported as -16 million, -47 million, and -5 million yuan respectively, with corresponding figures for net profit excluding non-recurring items being -22 million, -51 million, and -7 million yuan [1] Group 2 - Huayi Technology raised a total of 250.04 million yuan from its initial public offering, with a net amount of 193.90 million yuan after expenses [2] - The company planned to raise 391.69 million yuan for projects including smart testing equipment upgrades, testing center construction, R&D center construction, repayment of bank loans, and working capital [2] - The total issuance expenses for the initial public offering amounted to 5.61 million yuan, with underwriting and sponsorship fees being 35 million yuan [2]
中信证券:业绩预期稳健、创新加速兑现 医药政策优化趋势延续
智通财经网· 2026-01-27 01:53
智通财经APP获悉,中信证券发布研报称,展望2026年医药投资趋势,无论是中国医药企业在创新领域 的集中兑现,还是政策端出台支持创新药械、优化集采、推动商保等一系列产业支持政策,医疗健康产 业的内外因催化因素都有望延续,医疗健康产业开始逐步重新回归到临床价值和需求导向的市场价格定 价体系,带来稳定且持续的国内医药市场环境和长坡厚雪的发展主基调,上市公司也有望迎来持续且稳 定的业绩增长趋势,带来行业成长高确定性的贝塔。 因此该行认为医药行业将是有望继续维持超配的行业,从横向维度上,建议2026年围绕以下几条主线进 行布局:1)创新驱动和国际化——在反内卷的国内政策环境下,关注创新驱动和国际化出海的相关标 的;2)自主可控——该行预计在未来可能还会陆续面临地缘政治扰动带来的风险,应更多关注自主可控 下核心零部件、试剂、科研上游的进口替代进程加速的相关标的;3)新政新气象——受益于集采优化、 医保三个支付、消费刺激政策和国企改革的相关标的。 中信证券主要观点如下: 25Q4/H2医疗健康产业整体来看业绩表现预期较为稳健,同时该行看到医药和医疗企业的创新正在加速 兑现为业绩端的增长 该行对重点覆盖的76家医药公司25 ...
通信ETF华夏(515050)连续5日吸金2.43亿元,中信证券:AI产业趋势明确,持续看好光通信板块
Mei Ri Jing Ji Xin Wen· 2026-01-27 01:20
Core Insights - The AI computing sector, represented by optical modules CPO, optical communication, and PCB, is experiencing fluctuations while capital is accelerating its investment [1] - The largest communication ETF, Huaxia (515050), has seen a continuous net inflow of 243 million yuan over the past five days, with a total scale exceeding 8 billion yuan [1] - The ETF focuses on electronic (chips, PCBs, consumer electronics) and communication (optical modules, servers) hardware, with CPO and CPB concept stocks accounting for over 76% of its weight, the highest in the market [1] Industry Analysis - According to CITIC Securities, the explosive demand for AI computing is driving upgrades in the optical communication industry, with ongoing capital expansion from overseas cloud providers and TSMC, indicating strong demand for AI infrastructure [1] - There is a current short-term supply gap for high-speed optical chips and materials, but upstream manufacturers are actively expanding production, and the penetration rate of silicon photonics is expected to alleviate supply chain bottlenecks [1] - Technological advancements, particularly NPO with its low power consumption, high bandwidth, and maintainability advantages, are becoming a key transitional solution at the Scaleup level, with leading companies already positioning themselves to drive the industry towards more efficient optical interconnection architectures [1] - The development potential of domestic optical communication leading companies is viewed positively, maintaining a "stronger than the market" rating for the communication industry [1]
钧达股份(02865)股东将股票由中信证券经纪香港转入香港上海汇丰银行 转仓市值2.30亿港元
智通财经网· 2026-01-27 01:01
智通财经APP获悉,香港联交所最新资料显示,1月26日,钧达股份(02865)股东将股票由中信证券经纪 香港转入香港上海汇丰银行,转仓市值2.30亿港元,占比9.29%。 钧达股份公布,公司A 股股票(证券简称:钧达股份,证券代码:002865)连续 3 个交易日内(2026 年 1 月 22 日、2026 年 1 月 23 日、2026 年 1 月 26 日)收盘价格涨幅累计偏离值达到 20%。根据《深圳证券 交易所交易规则》的相关规定,属于股票交易异常波动的情况。 ...
钧达股份股东将股票由中信证券经纪香港转入香港上海汇丰银行 转仓市值2.30亿港元
Zhi Tong Cai Jing· 2026-01-27 01:01
Core Viewpoint - The stock of JunDa Co., Ltd. (002865) has experienced significant trading activity, with a notable transfer of shares and a substantial price increase over a short period, indicating potential market interest and volatility [1] Group 1: Share Transfer - On January 26, shareholders of JunDa Co., Ltd. transferred shares from CITIC Securities Brokerage Hong Kong to HSBC Hong Kong, with a total market value of HKD 230 million, representing 9.29% of the company's shares [1] Group 2: Stock Price Movement - JunDa Co., Ltd. reported that its A-share stock has seen a cumulative price increase of 20% over three consecutive trading days (January 22, January 23, and January 26, 2026), which qualifies as an abnormal fluctuation in stock trading according to the Shenzhen Stock Exchange regulations [1]
博安生物(06955)股东将股票由中国证券登记结算香港转入中信证券经纪香港 转仓市值3.46亿港元
智通财经网· 2026-01-27 00:59
博安生物公布,公司董事会已获控股股东绿叶制药集团知会,根据与可交换优先股相关的认购协议的条 款,拟安排绿叶制药的全资附属公司山东绿叶制药有限公司于2026年1月27日向发行人进一步于市场转 让1198.66万股H股完成拟议转让。 智通财经APP获悉,香港联交所最新资料显示,1月26日,博安生物(06955)股东将股票由中国证券登记 结算香港转入中信证券经纪香港,转仓市值3.46亿港元,占比6.32%。 ...
博安生物股东将股票由中国证券登记结算香港转入中信证券经纪香港 转仓市值3.46亿港元
Zhi Tong Cai Jing· 2026-01-27 00:59
博安生物公布,公司董事会已获控股股东绿叶制药集团知会,根据与可交换优先股相关的认购协议的条 款,拟安排绿叶制药的全资附属公司山东绿叶制药有限公司于2026年1月27日向发行人进一步于市场转 让1198.66万股H股完成拟议转让。 香港联交所最新资料显示,1月26日,博安生物(06955)股东将股票由中国证券登记结算香港转入中信证 券经纪香港,转仓市值3.46亿港元,占比6.32%。 ...
中信证券:掘金商业航天产业链上游合金材料
Xin Lang Cai Jing· 2026-01-27 00:49
中信证券研究 文|李超 俞腾 商业航天在可复用迭代与星座ITU时限共振下,发射与制造进入刚性放量,材料端出现"乘数效应"。我 们看好四类核心材料的产业化加速:高强高导铜合金(液体火箭发动机推力室内壁)、铌合金(二级真 空喷管与高工况推力室)、钽合金(抗辐照与星载)及高温合金(发动机热端部件)。 炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! ▍发射端的景气度与可复用渗透率是材料需求"乘数效应"的核心来源。 2025年全球火箭发射329次,其中商业航天发射214次,占比约65%;中国发射92次,商业航天占比 50%;美国发射198次,商业航天占比82%,商业属性已成为行业增长的主要驱动力。在星座端,我国 近期新增申报低轨卫星20.3万颗,叠加原有项目,申报总数已突破25.5万颗。在ITU"7-9-12-14年"强制 发射约束下,高密度发射窗口效应将把火箭与卫星制造推入"刚性放量"的轨道。 | 140 285 MIT 2017 | | | | | --- | --- | --- | --- | | 时间 | 政策名称 | 爱布机构 | 横心内容与意义 | | 2014 | 《国务院关于创 ...
中信证券:预计2026年内全年理财规模有望达到35-36万亿元
Xin Lang Cai Jing· 2026-01-27 00:46
Core Insights - The report from CITIC Securities indicates that by the end of 2025, the total market size of bank wealth management is expected to reach 33.29 trillion yuan, with fixed-income products remaining the dominant type [1] - Despite a better performance in the equity market, the overall risk appetite for bank wealth management has not significantly increased due to constraints from liability clientele and net asset value stability [1] - The forecast for the total wealth management scale in 2026 is projected to reach between 35 to 36 trillion yuan [1] Asset Allocation - In terms of asset allocation, deposits have become the most increased asset in bank wealth management since last year, while the increase in equity holdings has been very limited [1] - Multi-asset allocations in the second half of last year were primarily achieved through public fund products [1] Strategy Outlook - The strategy for the fixed-income portion is expected to maintain the current deposit ratio, with a focus on stable credit configurations to cope with bond market fluctuations [1] - For multi-asset investments, overseas bonds, fixed-income plus funds, and commodities are anticipated to be important directions for enhancing returns, although this needs to be observed in conjunction with liability clientele perspectives and market conditions [1] - The overall increase in risk appetite in the wealth management market is expected to be a long-term process [1]